|
1
|
Gersh BJ, Sliwa K, Mayosi BM and Yusuf S:
Novel therapeutic concepts: the epidemic of cardiovascular disease
in the developing world: global implications. Eur Heart J.
31:642–648. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Moore KJ and Tabas I: Macrophages in the
pathogenesis of atherosclerosis. Cell. 145:341–355. 2011.
View Article : Google Scholar
|
|
3
|
Gautier EL, Jakubzick C and Randolph GJ:
Regulation of the migration and survival of monocyte subsets by
chemokine receptors and its relevance to atherosclerosis.
Arterioscler Thromb Vasc Biol. 29:1412–1418. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gerrity RG: The role of the monocyte in
atherogenesis: I. Transition of blood-borne monocytes into foam
cells in fatty lesions. Am J Pathol. 103:181–190. 1981.PubMed/NCBI
|
|
5
|
Swirski FK, Pittet MJ, Kircher MF, Aikawa
E, Jaffer FA, Libby P and Weissleder R: Monocyte accumulation in
mouse atherogenesis is progressive and proportional to extent of
disease. Proc Natl Acad Sci USA. 103:10340–10345. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ylä-Herttuala S, Palinski W, Rosenfeld ME,
Parthasarathy S, Carew TE, Butler S, Witztum JL and Steinberg D:
Evidence for the presence of oxidatively modified low density
lipoprotein in atherosclerotic lesions of rabbit and man. J Clin
Invest. 84:1086–1095. 1989.PubMed/NCBI
|
|
7
|
Colles SM, Maxson JM, Carlson SG and
Chisolm GM: Oxidized LDL-induced injury and apoptosis in
atherosclerosis. Potential roles for oxysterols. Trends Cardiovasc
Med. 11:131–138. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Salvayre R, Auge N, Benoist H and
Negre-Salvayre A: Oxidized low-density lipoprotein-induced
apoptosis. Biochim Biophys Acta. 1585:213–221. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Napoli C: Oxidation of LDL, atherogenesis,
and apoptosis. Ann NY Acad Sci. 1010:698–709. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Stoneman VE and Bennett MR: Role of
apoptosis in atherosclerosis and its therapeutic implications. Clin
Sci (Lond). 107:343–354. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tabas I: Apoptosis and efferocytosis in
mouse models of atherosclerosis. Curr Drug Targets. 8:1288–1296.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Seimon T and Tabas I: Mechanisms and
consequences of macrophage apoptosis in atherosclerosis. J Lipid
Res. 50:S382–S387. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Verheye S, Martinet W, Kockx MM, Knaapen
MW, Salu K, Timmermans JP, Ellis JT, Kilpatrick DL and De Meyer GR:
Selective clearance of macrophages in atherosclerotic plaques by
autophagy. J Am Coll Cardiol. 49:706–715. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
De Meyer I, Martinet W, Schrijvers DM,
Timmermans JP, Bult H and De Meyer GR: Toll-like receptor 7
stimulation by imiquimod induces macrophage autophagy and
inflammation in atherosclerotic plaques. Basic Res Cardiol.
107:2692012.PubMed/NCBI
|
|
15
|
Razani B, Feng C, Coleman T, Emanuel R,
Wen H, Hwang S, Ting JP, Virgin HW, Kastan MB and Semenkovich CF:
Autophagy links inflammasomes to atherosclerotic progression. Cell
Metab. 15:534–544. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liao X, Sluimer JC, Wang Y, Subramanian M,
Brown K, Pattison JS, Robbins J, Martinez J and Tabas I: Macrophage
autophagy plays a protective role in advanced atherosclerosis. Cell
Metab. 15:545–553. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Axe EL, Walker SA, Manifava M, Chandra P,
Roderick HL, Habermann A, Griffiths G and Ktistakis NT:
Autophagosome formation from membrane compartments enriched in
phosphatidylinositol 3-phosphate and dynamically connected to the
endoplasmic reticulum. J Cell Biol. 182:685–701. 2008. View Article : Google Scholar
|
|
18
|
Hayashi-Nishino M, Fujita N, Noda T,
Yamaguchi A, Yoshimori T and Yamamoto A: A subdomain of the
endoplasmic reticulum forms a cradle for autophagosome formation.
Nat Cell Biol. 11:1433–1437. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hailey DW, Rambold AS, Satpute-Krishnan P,
Mitra K, Sougrat R, Kim PK and Lippincott-Schwartz J: Mitochondria
supply membranes for autophagosome biogenesis during starvation.
Cell. 141:656–667. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tooze SA and Yoshimori T: The origin of
the autophagosomal membrane. Nat Cell Biol. 12:831–835. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ravikumar B, Moreau K, Jahreiss L, Puri C
and Rubinsztein DC: Plasma membrane contributes to the formation of
pre-autophagosomal structures. Nat Cell Biol. 12:747–757. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Goligorsky MS: SIRTing out the link
between autophagy and ageing. Nephrol Dial Transplant.
25:2434–2436. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Schrijvers DM, De Meyer GR and Martinet W:
Autophagy in atherosclerosis: a potential drug target for plaque
stabilization. Arterioscler Thromb Vasc Biol. 31:2787–2791. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Martinet W and De Meyer GR: Autophagy in
atherosclerosis: a cell survival and death phenomenon with
therapeutic potential. Circ Res. 104:304–317. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Martinez J, Almendinger J, Oberst A, Ness
R, Dillon CP, Fitzgerald P, Hengartner MO and Green DR:
Microtubule-associated protein 1 light chain 3 alpha
(LC3)-associated phagocytosis is required for the efficient
clearance of dead cells. Proc Natl Acad Sci USA. 108:17396–17401.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yu W, Fu YC, Chen CJ, Wang X and Wang W:
SIRT1: a novel target to prevent atherosclerosis. J Cell Biochem.
108:10–13. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Norata GD, Marchesi P, Passamonti S,
Pirillo A, Violi F and Catapano AL: Anti-inflammatory and
anti-atherogenic effects of cathechin, caffeic acid and
trans-resveratrol in apolipoprotein E deficient mice.
Atherosclerosis. 191:265–271. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang Z, Zou J, Cao K, Hsieh TC, Huang Y
and Wu JM: Dealcoholized red wine containing known amounts of
resveratrol suppresses atherosclerosis in hypercholesterolemic
rabbits without affecting plasma lipid levels. Int J Mol Med.
16:533–540. 2005.
|
|
29
|
Zhang QJ, Wang Z, Chen HZ, Zhou S, Zheng
W, Liu G, Wei YS, Cai H and Liu DP: Endothelium-specific
overexpression of class III deacetylase SIRT1 decreases
atherosclerosis in apolipoprotein E-deficient mice. Cardiovasc Res.
80:191–199. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li L, Zhang HN, Chen HZ, Gao P, Zhu LH, Li
HL, Lv X, Zhang QJ, Zhang R, Wang Z, She ZG, Zhang R, Wei YS, Du
GH, Liu DP and Liang CC: SIRT1 acts as a modulator of neointima
formation following vascular injury in mice. Circ Res.
108:1180–1189. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Houtkooper RH, Pirinen E and Auwerx J:
Sirtuins as regulators of metabolism and healthspan. Nat Rev Mol
Cell Biol. 13:225–238. 2012.PubMed/NCBI
|
|
32
|
Mattagajasingh I, Kim CS, Naqvi A,
Yamamori T, Hoffman TA, Jung SB, DeRicco J, Kasuno K and Irani K:
SIRT1 promotes endothelium-dependent vascular relaxation by
activating endothelial nitric oxide synthase. Proc Natl Acad Sci
USA. 104:14855–14860. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Brunet A, Sweeney LB, Sturgill JF, Chua
KF, Greer PL, Lin Y, Tran H, Ross SE, Mostoslavsky R, Cohen HY, Hu
LS, Cheng HL, Jedrychowski MP, Gygi SP, Sinclair DA, Alt FW and
Greenberg ME: Stress-dependent regulation of FOXO transcription
factors by the SIRT1 deacetylase. Science. 303:2011–2015. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Stein S and Matter CM: Protective roles of
SIRT1 in atherosclerosis. Cell Cycle. 10:640–647. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lee IH, Cao L, Mostoslavsky R, Lombard DB,
Liu J, Bruns NE, Tsokos M, Alt FW and Finkel T: A role for the
NAD-dependent deacetylase Sirt1 in the regulation of autophagy.
Proc Natl Acad Sci USA. 105:3374–3379. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kockx MM, De Meyer GR, Buyssens N, Knaapen
MW, Bult H and Herman AG: Cell composition, replication, and
apoptosis in atherosclerotic plaques after 6 months of cholesterol
withdrawal. Circ Res. 83:378–387. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Nowicki M, Zabirnyk O, Duerrschmidt N,
Borlak J and Spanel-Borowski K: No upregulation of lectin-like
oxidized low-density lipoprotein receptor-l in serum-deprived
EAhy926 endothelial cells under oxLDL exposure, but increase in
autophagy. Eur J Cell Biol. 86:605–615. 2007. View Article : Google Scholar
|
|
38
|
Yoshimori T: Autophage: a regulated bulk
degradation process inside cells. Biochem Biophys Res Commm.
313:453–458. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Singh R and Cuervo AM: Autophagy in the
cellular energetic balance. Cell Metab. 13:495–504. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Singh R, Kaushik S, Wang Y, Xiang Y, Novak
I, Komatsu M, Tanaka K, Cuervo AM and Czaja MJ: Autophagy regulates
lipid metabolism. Nature. 458:1131–1135. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Singh R and Cuervo AM: Lipophagy:
connecting autophagy and lipid metabolism. Int J Cell Biol.
2012:2820412012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Liu K and Czaja MJ: Regulation of lipid
stores and metabolism by lipophagy. Cell Death Differ. 20:3–11.
2013. View Article : Google Scholar
|
|
43
|
Ouimet M, Franklin V, Mak E, Liao X, Tabas
I and Marcel YL: Autophagy regulates cholesterol efflux from
macrophage foam cells via lysosomal acid lipase. Cell Metab.
13:655–667. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kiffin R, Bandyopadhyay U and Cuervo AM:
Oxidative stress and autophagy. Antioxid Redox Signal. 8:152–162.
2006. View Article : Google Scholar
|
|
45
|
Ohsumi Y: Molecular dissection of
autophagy: two ubiquitin-like systems. Nat Rev Mol Cell Biol.
2:211–216. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Shintani T and Klionsky DJ: Autophagy in
health and disease: a double-edged sword. Science. 306:990–995.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Lum JJ, DeBerardinis RJ and Thompson CB:
Autophagy in metazoans: cell survival in the land of plenty. Nat
Rev Mol Cell Biol. 6:439–448. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Li S, Sun Y, Liang CP, Thorp EB, Han S,
Jehle AW, Saraswathi V, Pridgen B, Kanter JE, Li R, Welch CL, Hasty
AH, Bornfeldt KE, Breslow JL, Tabas I and Tall AR: Defective
phagocytosis of apoptotic cells by macrophages in atherosclerotic
lesions of ob/ob mice and reversal by a fish oil diet. Circ Res.
105:1072–1082. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Yancey PG, Blakemore J, Ding L, Fan D,
Overton CD, Zhang Y, Linton MF and Fazio S: Macrophage LRP-1
controls plaque cellularity by regulating efferocytosis and Akt
activation. Arterioscler Thromb Vasc Biol. 30:787–795. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Jehle AW, Gardai SJ, Li S, Linsel-Nitschke
P, Morimoto K, Janssen WJ, Vandivier RW, Wang N, Greenberg S, Dale
BM, Qin C, Henson PM and Tall AR: ATP-binding cassette transporter
A7 enhances phagocytosis of apoptotic cells and associated ERK
signaling in macrophages. J Cell Biol. 174:547–556. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
He X, Andersson G, Lindgren U and Li Y:
Resveratrol prevents RANKL-induced osteoclast differentiation of
murine osteoclast progenitor RAW 264.7 cells through inhibition of
ROS production. Biochem Biophys Res Commun. 401:356–362. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Peled T, Shoham H, Aschengrau D, Yackoubov
D, Frei G, Rosenheimer GN, Lerrer B, Cohen HY, Nagler A, Fibach E
and Peled A: Nicotinamide, a SIRT1 inhibitor, inhibits
differentiation and facilitates expansion of hematopoietic
progenitor cells with enhanced bone marrow homing and engraftment.
Exp Hematol. 40:342–355. 2012. View Article : Google Scholar
|
|
53
|
Zhang JG, Zhao G, Qin Q, Wang B, Liu L,
Liu Y, Deng SC, Tian K and Wang CY: Nicotinamide prohibits
proliferation and enhances chemosensitivity of pancreatic cancer
cells through deregulating SIRT1 and Ras/Akt pathways.
Pancreatology. 13:140–146. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Stein S, Lohmann C, Schäfer N, Hofmann J,
Rohrer L, Besler C, Rothgiesser KM, Becher B, Hottiger MO, Borén J,
McBurney MW, Landmesser U, Lüscher TF and Matter CM: SIRT1
decreases Lox-1-mediated foam cell formation in atherogenesis. Eur
Heart J. 31:2301–2309. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Guarente L and Franklin H: Epstein
Lecture: Sirtuins, aging, and medicine. N Engl J Med.
364:2235–2244. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Chen Lf, Fischle W, Verdin E and Greene
WC: Duration of nuclear NF-kappaB action regulated by reversible
acetylation. Science. 293:1653–1657. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Albani D, Polito L, Batelli S, De Mauro S,
Fracasso C, Martelli G, Colombo L, Manzoni C, Salmona M, Caccia S,
Negro A and Forloni G: The SIRT1 activator resveratrol protects
SK-N-BE cells from oxidative stress and against toxicity caused by
alpha-synuclein or amyloid-beta 1–42 peptide. J Neurochem.
110:1445–1456. 2009.
|
|
58
|
Wu Y, Li X, Zhu JX, Xie W, Le W, Fan Z,
Jankovic J and Pan T: Resveratrol-activated AMPK/SIRT1/autophagy in
cellular models of Parkinson’s disease. Neurosignals. 19:163–174.
2011.PubMed/NCBI
|
|
59
|
Takeda-Watanabe A, Kitada M, Kanasaki K
and Koya D: SIRT1 inactivation induces inflammation through the
dysregulation of autophagy in human THP-1 cells. Biochem Biophys
Res Commun. 427:191–196. 2012. View Article : Google Scholar : PubMed/NCBI
|
